We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 908

Fifth Circuit Affirms Defense Verdict and Dismissals of Off-Label FCA Claims
  • Sidley Austin LLP
  • USA
  • June 13 2017

Last week, the Fifth Circuit affirmed a defense verdict and the earlier dismissal of several False Claims Act claims related to the alleged off-label


Eleventh Circuit Rules That Reasonable Interpretations of Ambiguous Regulations Can Trigger FCA Liability
  • Sidley Austin LLP
  • USA
  • June 12 2017

Noncompliance with ambiguous regulations often presents a weak case for an FCA suit. A growing number of courts (as discussed here and here) have


Recent DOJ Settlements Reflect Post-Yates Trend in Holding Individuals Financially Accountable
  • Sidley Austin LLP
  • USA
  • June 9 2017

In the wake of the Yates memo eighteen months ago, DOJ offered an early signal that its commitment to focus more on individual accountability would


Bipartisan group of senators reintroduces CHRONIC Care Act
  • Sidley Austin LLP
  • USA
  • June 7 2017

A bipartisan group of senators comprising US Senate Finance Committee Chairman Orrin Hatch (Republican, Utah), Finance Committee Ranking Democratic


China Food and Drug Administration Announces Penalties for Clinical Trial Data Integrity Violations
  • Sidley Austin LLP
  • China
  • May 31 2017

On May 24, 2017, the China Food and Drug Administration (CFDA) issued its 2017 Circular No. 63 (the Circular), setting out penalties for clinical


Third Circuit Provides New Guidance on Escobar’s Materiality Requirement in Healthcare Cases
  • Sidley Austin LLP
  • USA
  • May 24 2017

In a recent opinion, the Third Circuit provided new guidance on the application of Escobar's "heightened" materiality standard to cases involving


House narrowly passes American Health Care Act
  • Sidley Austin LLP
  • USA
  • May 24 2017

On May 4 2017 the US House of Representatives passed the American Health Care Act seven years after Republicans pledged to repeal the Affordable Care


Court issues important decision for dietary supplement industry
  • Sidley Austin LLP
  • USA
  • May 17 2017

On April 18 2017 Judge Vasquez granted summary judgment to Bayer in a consumer class action over its probiotic dietary supplement


European Commission Launches 'Excessive Pricing' Investigation in Pharma Sector
  • Sidley Austin LLP
  • European Union, Italy, United Kingdom
  • May 16 2017

The European Commission announced yesterday that it has launched a formal investigation into Aspen Pharma's pricing of five cancer drugs. The


Bipartisan Group of Senators Reintroduces CHRONIC Care Act; Senate Finance Committee Could Hold Markup in May
  • Sidley Austin LLP
  • USA
  • May 9 2017

U.S. Senate Finance Committee Chairman Orrin Hatch, R-Utah; Finance Committee Ranking Democratic Member Ron Wyden, D-Ore.; Sen. Johnny Isakson, R-Ga